Drilldown: Medicines - Pharmacopedia

Choose a table:

Medicines (732)

Medicines > classes

: Anticonvulsant

or Antidepressant

or Dissociative

Use the filters below to narrow your results.

None (18)

Irreversible non-selective MAO inhibitor (3) · NMDA antagonist (3) · Selective norepinephrine reuptake inhibitor (3) · Serotonin and norepinephrine reuptake inhibitor (3) · NMDA antagonist; sigma receptor agonist (2) · Serotonin–norepinephrine reuptake inhibitor (2) · Sodium channel blocker (2)

Other values:

None (56) · Depression, anxiety, neuropathic pain, fibromyalgia, chronic musculoskeletal pain (1) · Treatment-resistant depression (TRD) in adults, as adjunct to oral antidepressant (FDA-approved March 2019). Depressive symptoms in adults with MDD with acute suicidal ideation or behavior (FDA-approved Aug 2020). (1)

None (56) · 25 mg (1) · Induction (TRD): 56 mg intranasal twice weekly × 4 weeks. Maintenance: 56-84 mg once weekly × 4 weeks, then 56-84 mg every 1-2 weeks. For acute suicidality: 84 mg twice weekly × 4 weeks. Administered under medical supervision in REMS-certified site. (1)

None (56) · 25 mg, 50 mg, 100 mg tablets; oral concentrate 20 mg/mL (1) · 28 mg/device (each dose uses 2 devices) (1)

None (56) · 200 mg/d (1) · 84 mg per session (1)

None (55) · Intranasal (under direct medical supervision) (1) · Oral (2)

None (55) · Anxiolysis classically 3-4 weeks, continuing improvement to 8-12 weeks (1) · Mood: 2–4 weeks. Pain: often within 1–2 weeks. (1) · Within hours of first administration (1)

None (55) · Acute effect ~24 hours; cumulative effect builds with repeated dosing (1) · Chronic daily dosing (1) · Long (1)

None (55) · ~12 hours (1) · ~26 h (sertraline; range 13-45 h, longer in females); ~62-104 h (N-desmethylsertraline, weakly active) (1) · ~7-12 hours (1)

None (55) · Absolute bioavailability not precisely characterized; food modestly increases exposure (1) · ~48% intranasal (1) · ~50% (highly variable) (1)

None (55) · Avoid; may cause fetal harm (1) · Category C (1) · Category C'"`UNIQ--ref-0000008F-QINU`"' (1)

None (55) · Rx, Schedule III (US). REMS program required. (1) · Rx-only (1) · Rx-only in US (1)

Showing below up to 58 results in range #1 to #58.

2

2-FDCK

3

4

4-MeO-PCP

A

B

Brivaracetam

C

D

E

Ephenidine

F

I

L

M

N

O

O-PCE

P

Perampanel

R

S

T

V

X

Xenon

Z

Zonisamide

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"